XML 79 R50.htm IDEA: XBRL DOCUMENT
v3.25.4

Accounting Standards and Basis of Preparation - Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries (Details) | 12 Months Ended
--- | ---
Jun. 30, 2025 | Jun. 30, 2024
Moolec Science Limited [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | United Kingdom |
Equity interest | [1] | 100.00% |
AG Biomolecules LLC [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Production and commercialization of agricultural products |
Country of incorporation and principal place of business |  | United States |
Equity interest | [1] | 100.00% |
ValoraSoy S.A.[Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Production and commercialization of agricultural products |
Country of incorporation and principal place of business |  | Argentina |
Equity interest | [1] | 100.00% |
Nutrecon LLC [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | United States |
Equity interest | [1] | 100.00% |
SynBio Powerlabs [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Production and commercialization of fermentation products |
Country of incorporation and principal place of business |  | Finland |
Equity interest | [2] | 90.00% |
Gentle Tech [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | British Virgin Islands |
Equity interest | [1],[3] | 100.00% | 50.00%
Gentle Farming [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | British Virgin Islands |
Equity interest | [1],[3] | 51.00% | 51.00%
G-FAS [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Production and commercialization of sustainable agricultural equipment |
Country of incorporation and principal place of business |  | Argentina |
Equity interest | [1],[3] | 64.00% | 64.00%
Bioceres Group Limited [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | United Kingdom |
Equity interest | [1] | 100.00% | 100.00%
Bioceres Crop Solutions (BIOX) [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Research and development |
Country of incorporation and principal place of business |  | United States |
Equity interest | [4] | 29.30% | 28.75%
Bioceres LLC [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | United States |
Equity interest | [3] | 100.00% | 100.00%
Bioceres S.A [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | Argentina |
Equity interest | [3] | 89.93% | 79.72%
Bioceres Tech Services LLC [Member] |  |  |
Schedule of Information related to Company’s Share of Voting Rights in its Subsidiaries [Line Items] |  |  |
Principal activities |  | Investment in subsidiaries |
Country of incorporation and principal place of business |  | United States |
Equity interest | [3] | 100.00% | 100.00%
[1] | Direct interest held by Moolec Science SA.
[2] | Direct interest held by Nutrecon LLC.
[3] | Direct interests held by Bioceres Group Limited.
[4] | Since 2023, the Group exercises “de facto control” over Bioceres Crop Solutions Corp, however, as stated in note Note 1 – The Group’s business reorganization and general information - “The Bioceres Group Business Combination Agreement”, Bioceres Group Limited lost the “de facto control” on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025, and the investment in it was measured using the equity method. The Group’s consolidated result includes the results of that entity up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.

X
- Definition The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 16 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_ii&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_ii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 12 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_b&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 19B -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_b&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The name of a subsidiary. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_i&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 12 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_a&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 16 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_i&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 19B -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NameOfSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph 19B -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_MoolecScienceLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_AGBiomoleculesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_ValoraSoySAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_NutreconLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_SynBioPowerlabsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleTechMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleFarmingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GFASMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresGroupLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsBIOXMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresTechServicesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |